Felix Baker, Director at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 57,449 shares at $120.12 ($6.9M) on 2019-05-30, disclosed to the SEC on 2019-05-30.
Open-market sale of $6.9M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.12 | 1,845 | $222K | 3.2% |
| 2 | $120.12 | 15,355 | $1.8M | 26.5% |
| 3 | $120.77 | 2,729 | $330K | 4.7% |
| 4 | $120.77 | 22,720 | $2.7M | 39.5% |
| 5 | $122.31 | 1,587 | $194K | 2.8% |
| 6 | $122.31 | 13,213 |
| $1.6M |
| 23.3% |
| Total | $120.97 avg | 57,449 | $6.9M | 100% |
| Filing → |
| MDGL | BUY | 2025-08-20 | $48.5M | — | Filing → |
| KALA | BUY | 2024-12-31 | $4.0M | — | Filing → |
| MDGL | BUY | 2023-11-15 | $31.4M | — | Filing → |